Dr. Girotto is the co-director of Connecticut Children’s nationally recognized Antimicrobial Stewardship Program. She has been involved in many projects and processes that have resulted in improved antimicrobial use in both the inpatient and outpatient areas. In addition to antimicrobial stewardship, Dr. Girotto’s clinical and research interests include immunizations and pediatric infectious diseases outcomes. Dr. Girotto has provided more than 100 clinical presentations to healthcare providers.  She has also had 75 research posters presented and published 65 journal articles and 8 book chapters.

PharmD, University of Connecticut School of Pharmacy

Pediatric Pharmacy, Boston Children’s Hospital

  • Pediatric Pharmacotherapy Specialist
  • Infectious Disease Pharmacist
  • Clinical Professor and Assistant Department Head, Pharmacy Practice, University of Connecticut
  • Clinical Professor, Pediatrics, University of Connecticut
  • Wang EY & Girotto JE. Approaches to Reduce Use and Duration of Anti-MRSA Agents for Antimicrobial Stewardship Programs: A Review of Recent Literature. J Pharm Pract 2022 Oct 4. 
  • Basco SA, Girotto JE. Contemporary treatment of resistant gram-negative infections in pediatric patients. ID Clinics 2022 36:147-171 
  • Puckett LM, Newland J, Girotto JE. Advancing pediatric antimicrobial stewardship: Has pharmacodynamic dosing for Gram-negatives taken effect? Antimicrobial Stewardship & Healthcare Epidemiology 2021 1(1), E61.
  • Puckett LM, Rajkotia P, Baumgartner L, Robers AL, Maldonado Y, Girotto JE. Impact of Direct from Blood Culture Identification of Pathogens Paired with Antimicrobial Stewardship Interventions in a Pediatric Hospital. J Pediatr Pharmacol Ther 2021;26(8) 802-808.
  • Al-Mazraawy BO, Girotto JE. Comparing Vancomycin Area Under the Curve with a Pharmacist Protocol that Incorporates Trough and Maximum Doses at a Children’s Hospital. J Pediatr Pharmacol Ther Sept 2021;26(7) 74-745.